NXC-201 — Full data
Mar 2027
By end of March 2027, we expect to present 1-year follow-up data of enrolled patients, which we expect will drive BLA submission and commercial launch.Source filing
IMMX biotech catalysts & pipeline
IMMIX BIOPHARMA INC · Data as of 2026-10-25
Upcoming catalysts
NXC-201 — Full data
mid-2027
– NEXICART-2 final readout and BLA submission planned mid-2027 –Source filing